Alterations in the innate and adaptive immune system in a real-world cohort of multiple sclerosis patients treated with ocrelizumab

Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.

Détails bibliographiques
Publié dans:Clinical immunology (Orlando, Fla.). - 1999. - 259(2024) vom: 06. Feb., Seite 109894
Auteur principal: Beckers, L (Auteur)
Autres auteurs: Baeten, P, Popescu, V, Swinnen, D, Cardilli, A, Hamad, I, Van Wijmeersch, B, Tavernier, S J, Kleinewietfeld, M, Broux, B, Fraussen, J, Somers, V
Format: Article en ligne
Langue:English
Publié: 2024
Accès à la collection:Clinical immunology (Orlando, Fla.)
Sujets:Journal Article Research Support, Non-U.S. Gov't B cells Extended interval dosing High-dimensional flow cytometry Multiple sclerosis Ocrelizumab Treatment response ocrelizumab A10SJL62JY plus... Immunologic Factors Interleukin-12 187348-17-0 Antibodies, Monoclonal, Humanized